Rhythm Pharmaceuticals, Inc. (RYTM) is listed on NASDAQ in Pharmaceutical Stocks. It is $107.26, -4.68%, with a $7.4B market cap. RSI is 44.9, neutral. The latest reported quarter beat estimates. Insiders were net sellers across the listed trades.
Technical Analysis
RSI (14) 44.9 Neutral
Market Cap $7.4B
Volume 409.5K
Fundamentals — 10-Q Q2 2026
Revenue $131.4M
Net Income $-104.9M
EPS $-1.57
Gross Margin 87.8%
Operating Margin -76.8%
Net Margin -79.9%
Debt / Equity 0.9x
P/E Ratio -68.3x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Shulman Joseph | Chief Technical Officer | Sell | 5,079 | $119.75 | $608,210 | 2026 Aug 13 |
| Garfield Alastair | Chief Scientific Officer | Sell | 7,763 | $117.57 | $912,703 | 2026 Aug 13 |
| Lee Jennifer Kayden | EVP, Head of North America | Sell | 75,834 | $117.38 | $8.9M | 2026 Aug 13 |
| Mazabraud Yann | EVP, Head of International | Sell | 57,000 | $116.15 | $6.6M | 2026 Aug 12 |
| Tetrault Lynn A. | Director | Sell | 37,000 | $100.32 | $3.7M | 2026 Jun 22 |
| German Christopher Paul | Corporate Controller & CAO | Sell | 4,643 | $92.21 | $428,131 | 2026 May 15 |
| German Christopher Paul | Corporate Controller & CAO | Sell | 5,614 | $89.56 | $502,790 | 2026 Mar 4 |
| Cramer Pamela J. | Chief Human Resources Officer | Sell | 3,350 | $111.00 | $371,850 | 2025 Dec 11 |
| Cramer Pamela J. | Chief Human Resources Officer | Sell | 3,350 | $105.00 | $351,750 | 2025 Nov 20 |
| Cramer Pamela J. | Chief Human Resources Officer | Sell | 22,866 | $99.00 | $2.3M | 2025 Nov 10 |
| Shulman Joseph | Chief Technical Officer | Sell | 9,748 | $115.24 | $1.1M | 2025 Oct 30 |
| Shulman Joseph | Chief Technical Officer | Sell | 2,815 | $115.01 | $323,753 | 2025 Oct 28 |
| Shulman Joseph | Chief Technical Officer | Sell | 14,437 | $112.03 | $1.6M | 2025 Oct 16 |
| Shulman Joseph | Chief Technical Officer | Sell | 16,781 | $105.30 | $1.8M | 2025 Sep 2 |
| Shulman Joseph | Chief Technical Officer | Sell | 4,188 | $100.07 | $419,093 | 2025 Aug 21 |
| Smith Hunter C | Chief Financial Officer | Sell | 28,088 | $96.29 | $2.7M | 2025 Aug 13 |
| German Christopher Paul | Corporate Controller & CAO | Sell | 1,500 | $95.00 | $142,500 | 2025 Aug 12 |
| Shulman Joseph | Chief Technical Officer | Sell | 3,984 | $90.08 | $358,879 | 2025 Aug 11 |
| Cramer Pamela J. | Chief Human Resources Officer | Sell | 1,520 | $85.93 | $130,614 | 2025 Jul 29 |
| Smith Hunter C | Chief Financial Officer | Sell | 42,120 | $80.48 | $3.4M | 2025 Jul 9 |
Other Pharmaceutical Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $1,173.34 | 46.3 | $1.1T |
| | $268.01 | 58.6 | $645.9B |
| | $148.31 | 64.1 | $365.9B |
| | $33.30 | 38.4 | $2.0B |
Take RYTM further
- Browse Pharmaceutical Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put RYTM in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Rhythm Pharmaceuticals, Inc. next reports.
Set alerts on RYTM
Get notified when Rhythm Pharmaceuticals, Inc. hits your price targets or technical conditions are met.
Get Started Free